51 studies found for:    Open Studies | "Helicobacter Infections"
Show Display Options
Rank Status Study
21 Not yet recruiting The Diagnostic Validity of the Urea Breath Test
Condition: Helicobacter Pylori Infection
Intervention: Drug: Citric acid
22 Recruiting Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: Reverse hybrid therapy;   Drug: Standard triple therapy
23 Recruiting Volatile Markers in Digestive Cancer
Conditions: Colorectal Cancer;   Colorectal Adenoma;   Gastric Cancer;   Peptic Ulcer Disease;   Atrophic Gastritis;   Intestinal Metaplasia;   H.Pylori Infection;   Normal Control;   Average-risk General Population
Interventions: Procedure: Breath sampling for volatile marker detection;   Procedure: Upper endoscopy with biopsies;   Procedure: Colonoscopy with biopsies or lesion removal when required;   Procedure: Plasma/serum sampling;   Procedure: Faecal sample acquisition;   Procedure: Histological evaluation of the surgery material
24 Recruiting European Registry on the Management of Helicobacter Pylori Infection
Condition: H. Pylori Infection
25 Recruiting Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: N-acetylcysteine + PPI-amoxicillin-clarithromycin;   Drug: PPI-amoxicillin-clarithromycin
26 Recruiting Epidemiology of Helicobacter Pylori Infection Among Shanghai Children
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
27 Recruiting Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
Condition: Helicobacter Pylori Infection
Interventions: Drug: Pantoprazole;   Drug: Amoxicillin;   Drug: Clarithromycin;   Drug: Metronidazole;   Drug: Tetracycline;   Drug: Bismuth
28 Recruiting Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections
29 Recruiting Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
Conditions: Gastric Cancer;   Helicobacter Pylori Infection
Intervention: Drug: 10-day bismuth-based quadruple therapy
30 Recruiting Helicobacter Pylori Eradication Study in Parkinson's Disease
Conditions: Parkinson's Disease;   Helicobacter Pylori Infection
Interventions: Drug: Helicobacter pylori eradication therapy;   Drug: Placebo
31 Recruiting Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: Sequential therapy 10 days;   Drug: Sequential therapy 14 days;   Drug: Concomitant therapy 10 days;   Drug: Concomitant therapy 14 days
32 Not yet recruiting Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection
Condition: Early Gastric Cancer
33 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy
34 Not yet recruiting The Impact of Addition of Curcumin for 10 Days Triple Therapy, on the Eradication Rate of Helicobacter Pylori Infection
Condition: Positivity for Helicobacter Pylori
Intervention: Dietary Supplement: Curcumin
35 Recruiting Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Intervention: Drug: triple, quadruple, non-bismuth quadruple therapy
36 Unknown  Gallstones and Concomitant Gastric Helicobacter Pylori Infection
Condition: Cholelithiasis
37 Unknown  Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Dietary Supplement: InSan Bamboo Salt;   Dietary Supplement: Placebo
38 Unknown  Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections
Condition: Helicobacter Pylori Infection
Interventions: Drug: RA5-RACM7;   Drug: RA3-RACM7;   Drug: RA7-RACM7
39 Unknown  Antimicrobial Susceptibility for Helicobacter Pylori Eradication
Condition: Helicobacter Pylori Infection
Intervention: Other: OCA 10
40 Unknown  14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication
Condition: Helicobacter Pylori Infection
Intervention: Drug: PPI, amoxicillin, metronidazole and clarithromycin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-51) Show next page of results    Last Page
Indicates status has not been verified in more than two years